2015

Vormehr M, Diken M, Boegel S, Kreiter S, Türeci Ö, Sahin U: Mutanome directed cancer immunotherapy. Current opinion in immunology 2015, 39:14-22.
DOI; PubMed

Show abstract

Vormehr M, Schrörs B, Boegel S, Löwer M, Türeci Ö, Sahin U: Mutanome Engineered RNA Immunotherapy: Towards Patient-Centered Tumor Vaccination. Journal of Immunology Research 2015, 2015:1-6.
DOI

Show abstract

Scholtalbers J, Boegel S, Bukur T, Byl M, Goerges S, Sorn P, Loewer M, Sahin U, Castle JC: TCLP: an online cancer cell line catalogue integrating HLA type, predicted neo-epitopes, virus and gene expression. Genome medicine 2015, 7:118.
DOI; PubMed

Show abstract

Stadler CR, Bähr-Mahmud H, Plum LM, Schmoldt K, Kölsch AC, Türeci Ö, Sahin U: Characterization of the first-in-class T-cell-engaging bispecific single-chain antibody for targeted immunotherapy of solid tumors expressing the oncofetal protein claudin 6. OncoImmunology 2015, 5:e1091555.
DOI; PubMed

Show abstract

Poleganov MA, Eminli S, Beissert T, Herz S, Moon J, Goldmann J, Beyer A, Heck R, Burkhart I, Barea Roldan D, Türeci Ö, Yi K, Hamilton B, Sahin U: Efficient Reprogramming of Human Fibroblasts and Blood-Derived Endothelial Progenitor Cells Using Nonmodified RNA for Reprogramming and Immune Evasion. Human Gene Therapy 2015, 26:751-766.
DOI; PubMed

Show abstract

Malczyk AH, Kupke A, Prüfer S, Scheuplein VA, Hutzler S, Kreuz D, Beissert T, Bauer S, Hubich-Rau S, Tondera C, Eldin HS, Schmidt J, Vergara-Alert J, Süzer Y, Seifried J, Hanschmann K, Kalinke U, Herold S, Sahin U, Cichutek K, Waibler Z, Eickmann M, Becker S, Mühlebach MD: A Highly Immunogenic and Protective Middle East Respiratory Syndrome Coronavirus Vaccine Based on a Recombinant Measles Virus Vaccine Platform. Journal of virology 2015, 89:11654-11667.
DOI; PubMed

Show abstract

Diken M, Kreiter S, Kloke B, Sahin U: Current Developments in Actively Personalized Cancer Vaccination with a Focus on RNA as the Drug Format. Progress in tumor research 2015, 42:44-54.
PubMed

Show abstract

Jiménez Calvente C, Sehgal A, Popov Y, Kim YO, Zevallos V, Sahin U, Diken M, Schuppan D: Specific hepatic delivery of procollagen α1(I) small interfering RNA in lipid-like nanoparticles resolves liver fibrosis. Hepatology (Baltimore, Md.) 2015, 62:1285-1297.
DOI; PubMed

Show abstract

Paret C, Simon P, Vormbrock K, Bender C, Kölsch A, Breitkreuz A, Yildiz Ö, Omokoko T, Hubich-Rau S, Hartmann C, Häcker S, Wagner M, Roldan DB, Selmi A, Türeci Ö, Sahin U: CXorf61 is a target for T cell based immunotherapy of triple-negative breast cancer. Oncotarget 2015, 6:25356-25367.
DOI; PubMed

Show abstract

Boegel S, Scholtalbers J, Löwer M, Sahin U, Castle JC: In Silico HLA Typing Using Standard RNA-Seq Sequence Reads. Methods in molecular biology (Clifton, N.J.) 2015, 1310:247-258.
DOI; PubMed

Show abstract

Vallazza B, Petri S, Poleganov MA, Eberle F, Kuhn AN, Sahin U: Recombinant messenger RNA technology and its application in cancer immunotherapy, transcript replacement therapies, pluripotent stem cell induction, and beyond. Wiley interdisciplinary reviews. RNA 2015, 6:471-499.
DOI; PubMed

Show abstract

Maaß F, Wüstehube-Lausch J, Dickgießer S, Valldorf B, Reinwarth M, Schmoldt H, Daneschdar M, Avrutina O, Sahin U, Kolmar H: Cystine-knot peptides targeting cancer-relevant human cytotoxic T lymphocyte-associated antigen 4 (CTLA-4). Journal of peptide science: an official publication of the European Peptide Society 2015, 21:651-660.
DOI; PubMed

Show abstract

Bidmon N, Attig S, Rae R, Schröder H, Omokoko TA, Simon P, Kuhn AN, Kreiter S, Sahin U, Gouttefangeas C, van der Burg, Sjoerd H, Britten CM: Generation of TCR-engineered T cells and their use to control the performance of T cell assays. Journal of immunology (Baltimore, Md.: 1950) 2015, 194:6177-6189.
DOI; PubMed

Show abstract

Kang B, Okwieka P, Schöttler S, Seifert O, Kontermann RE, Pfizenmaier K, Musyanovych A, Meyer R, Diken M, Sahin U, Mailänder V, Wurm FR, Landfester K: Tailoring the stealth properties of biocompatible polysaccharide nanocontainers. Biomaterials 2015, 49:125-134.
DOI; PubMed

Show abstract

Kreiter S, Vormehr M, van de Roemer, Niels, Diken M, Löwer M, Diekmann J, Boegel S, Schrörs B, Vascotto F, Castle JC, Tadmor AD, Schoenberger SP, Huber C, Türeci Ö, Sahin U: Mutant MHC class II epitopes drive therapeutic immune responses to cancer. Nature 2015, 520:692-696.
DOI; PubMed

Show abstract

Foerster F, Strobl S, Kaps L, Weng S, Kim YO, Bros M, Diken M, Boegel S, Castle J, Bockamp E, Schuppan D: P0311. Balb/c and C57/Bl6 mice exhibit differences in their susceptibility and anti-tumor response to B16F10 melanoma liver metastasis. Journal of Hepatology 2015, 62:S425.
DOI

Show abstract

Omokoko T, Simon P, Türeci Ö, Sahin U: Retrieval of functional TCRs from single antigen-specific T cells: Toward individualized TCR-engineered therapies. Oncoimmunology 2015, 4:e1005523.
DOI; PubMed

Show abstract